Becker's Healthcare February 18, 2025
Andrew Cass

Private equity firm Sycamore Partners’ bid to acquire Walgreens Boots Alliance and take it private is still possible, Bloomberg reported Feb. 18.

CNBC’s David Faber upgraded the deal to “alive” on Feb. 18 after previously saying Jan. 27 that the deal was “mostly dead,” according to the report.

Bloomberg reported Jan. 31 that Sycamore had been talking with private credit firms about debt financing for a possible Walgreens deal.

Jeff Jonas, a portfolio manager at Gabelli Funds and a Walgreens investor, told Bloomberg that a prospective acquisition would be complicated because the drugstore chain carries a lot of debt, which makes a leveraged buyout challenging. He remains skeptical of a deal.

Walgreens announced Jan....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Walgreens PE deal back on the table: 5 things to know
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more
Pharma Pulse 2/20/25: Popping the Gross-to-Net Bubble, Prompting Better Care with Question Prompt Lists & more
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal
The Unique Challenges, Growth in the Business of Health-System Pharmacy

Share This Article